Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes
Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths
One product is being pulled from the market, and the other is receiving updated instructions for use.
AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs
Researchers developed several new AI models that could guide the management of patients with non-valvular atrial fibrillation. There is still some work to do in terms of accuracy, but they already appear to outperform the traditional risk scores being used today.
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension
The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH.
Philips pulls endovascular devices from market after safety issues prompt Class I recall
Philips is recalling all sizes of its Tack Endovascular System after 20 patient injuries were reported. Interventional cardiologists are urged to stop using the device immediately.

Stroke recovery specialists raise $25M to expand business

The funds are expected to go toward bringing in new employees and making other key additions as the company ramps up production of its flagship platform.

DOACs reduce stroke risk better than aspirin among high-risk ablation patients

Researchers presented the new data at Heart Rhythm 2021.

How the body's own immune response is harming some COVID-19 patients

Needless platelet activity in the lungs may be one of the primary reasons clinicians are seeing inflammation and blood clotting in critically ill COVID-19 patients.

Marijuana use among young adults not associated with a heightened risk of stroke

The authors tracked data from stroke patients, and healthy controls, between the ages of 15 and 49 years old.

Heart disease still the No. 1 killer in the US—COVID, stroke not far behind

Unhealthy lifestyle decisions and a fear of catching COVID-19 are putting people at an increased risk of heart disease, according to the American Heart Association.

Laser-assisted IVC filter removal device earns FDA’s breakthrough device designation

The FDA’s decision was based in part on two independent clinical studies published in 2020.

FDA grants breakthrough device designation to new AAA sealing system

The new system was designed to treat juxtarenal, pararenal and suprarenal AAA.

Primary care an essential first step on the road to recovery for stroke patients

The risk for recurrent stroke is nearly 8% in the first year after an ischemic stroke—and primary care teams play a big role in managing that risk.

Vascular & Endovascular

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs

ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

Philips pulls endovascular devices from market after safety issues prompt Class I recall